ArticlePregnancy (Hoboken, N.J.)2026
Placental pathology in fetuses with and without congenital heart defects.
Article in Pregnancy (Hoboken, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Placental histopathologic evaluation of pregnancies affected by congenital heart defects (CHDs) can provide insight into the mechanism connecting placental and fetal vascular systems. The objective of this study was to evaluate the prevalence of maternal vascular malperfusion (MVM) and fetal vascular malperfusion (FVM) lesions of the placenta in pregnancies with and without fetal CHD on blinded pathologic examination. Methods: This is a case-control study of pregnancies complicated by CHD at our institution from January 1, 2011 to June 25, 2021. Controls were matched to cases in a 2:1 ratio based on maternal age and gestational age at delivery. Placental and umbilical cord pathology slides were deidentified prior to standardized pathologic examination. There were two primary composite outcomes: MVM and FVM. The MVM composite included infarction and villous and vascular lesions. The FVM composite included thrombosis, villous lesions, and cord abnormalities. Primary composite outcomes were evaluated based on the presence or absence of a fetal CHD using Results: A total of 351 patients were included: 117 cases and 234 controls. The CHD cohort had higher rates of neonatal intensive care unit (NICU) admission (91.5% vs. 22.2%, Conclusions: On blinded pathology review, those with fetal CHD were more likely to have FVM lesions. MVM lesions did not show an association with CHD in our cohort.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.